Invex Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Invex Therapeutics has a total shareholder equity of A$5.7M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$6.1M and A$431.6K respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$6.03m |
| Equity | AU$5.69m |
| Total liabilities | AU$431.63k |
| Total assets | AU$6.12m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IXC's short term assets (A$6.1M) exceed its short term liabilities (A$431.6K).
Long Term Liabilities: IXC has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: IXC is debt free.
Reducing Debt: IXC has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IXC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: IXC has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 29.9% each year.